Cancer Epigenetics Society

We are delighted to confirm that our President & CEO, Dr. IM Bennani-Baiti, will be leading the panel discussion on “Combination therapies vs monotherapies” at the upcoming Epigenetic Therapeutic Targets Summit, taking place online on July 28, 2020.

The Summit is the very first and only virtual meeting which specifically looks at the new applications and challenges of progressing epigenetic drug candidates through early translational studies and clinical trials, such as developing potent and highly selective inhibitors with minimal off-target drug effects.

Dr. Bennani-Baiti is joining a stellar line-up of speakers from STORM therapeutics, Oryzon Genomics, Incyte, Epizyme, 4SC, GSK, Imago Biosciences, Omega Therapeutics, Genentech, Resverlogix Corp., Accent Therapeutics and more.

The Epigenetic Therapeutic Targets Summit is a rare opportunity to meet and hear from the world-class experts who are at the forefront of epigenetic research. We are looking forward to meeting you online on July 28.

You can find a full event guide available https://epigenetic-targets.com/whats-on/full-event-guide/

To register – visit Summit website.

Today is World Cancer Day!

The Cancer Epigenetics Society (Headquarters: Vienna; 155 member countries) and UICC - Union for International Cancer Control (Headquarters: Geneva; 171 member countries) celebrate today the work and dedication of all the cancer scientists and health professionals around the world who day after day are unraveling the causes of this disease, improving outcomes, and saving lives.

Today, we also celebrate all cancer survivors and their families and wish them the very best for a continuing remission.

This year's motto is "I am and I will": with everyone's support and dedication, cancer will become a chronic disease that can be largely prevented or managed.

The Cancer Epigenetics Society will continue working hard to get us there as fast as possible.

The Cancer Epigenetics Society is 3 years old today! In this relatively short time, the Cancer Epigenetics Society became the largest epigenetics society or association worldwide, and with members in 155 countries, also one of the largest international organizations!

The Society supports research & discovery in all fields of cancer and epigenetics, including research into chemical modifications of DNA and RNA, miRNAs and ncRNAs, histone PTMs, and chromatin remodeling machineries.

The Society brings together most scientists vested in the research of epigenetics and related fields, including those who have influenced the most the field, such as inventors of Solexa next generation sequencing (NGS) technology, 5-methylcytosine (5mC) bisulfite sequencing technique, Lasker Award and Breakthrough Prize laureates, members of the National Academy of Sciences, USA, and Fellows of the The Royal Society (of London).

The Society is also founder of the No to Cancer initiative, the only platform on Facebook to deliver practical health news in 35 languages!

We accepts year round applications from scientists, healthcare professionals, and students interested in cancer or epigenetics. ★Today only★, you may become a member ★for free★ at https://ces.b2sg.org/membership/sign-up/

For those interested in DNA methylation, the video below covers over a century of DNA methylation research and discoveries:
https://www.youtube.com/watch?v=-_hIJOUW97M

If you like it, please share it on your page and give it a 👍 on YouTube!

DNA methylation timeline The DNA methylation timeline (S. Winkler & I.M. Bennani-Baiti, Cancer Epigenetics Society). This YouTube video highlights the history of some of the most imp...

Largest biomedical research funded by the Bill & Melinda Gates Foundation finds no amount of alcohol to be safe! Advocates to change current "Drink in moderation" guideline.

The last Drink What do celebrities like Jennifer Lopez, Kim Kardashian West, Gerard Butler, Tyra Banks, Tim McGraw, Tobey Maguire, Samuel L. Jackson, and Ewan

As a member of the UICC - Union for International Cancer Control, the Cancer Epigenetics Society and the Editors of its “No to Cancer” project are proud to celebrate February the 4th, World Cancer Day 2018! Cancer awareness and prevention saves millions of lives, and we can all contribute to reducing the global burden of cancer, both by taking cancer preventive measures for one’s self and family, and by spreading the word. The UICC tagline “We can. I can” and the Cancer Epigenetics Society motto “Cancer affects all of us. Together we can beat it” have more meaning than ever! You may follow worldwide tweets at http://www.worldcancerday.org/

The Cancer Epigenetics Society launches the first multilingual FB page to support cancer patients and survivors in their mother tongue! The page will inform on some of the latest developments in cancer treatment and diagnosis and serve as a forum for survivors. The English (No to Cancer) and Bulgarian (Не на рака) versions are already up; other supported languages will be announced as they become available.

Cancer Epigenetics Society meets Taboo of Black Eyed Peas in Mexico City: https://youtu.be/o6Qj8FgmgXU

Great solo performance from Taboo of Black Eyed Peas in Mexico City! Taboo, a cancer survivor, performs at Club Banqueros in Mexico City and dedicates his performance to all Mexicans, Latino Americans, Indigenous people, and c...

Society member Gabriella Ficz publishes groundbreaking study on breast cancer initiation! More at https://ces.b2sg.org/cancer-initiating-epigenetics/

Epigenetic editing shows epigenetics as an early cancer-causing event Unexpected findings in early-stage breast cancer initiation thanks to epigenetic editing. Research conducted at the Queen Mary University of London by Cancer Epigenetics Society Member, Dr. Gabriella Ficz and her collaborators, shows that an epigenetic alteration of just one gene is sufficient to dr...

Stephan Beck, Editor of Cancer Epigenetics The Cancer Epigenetics Society is happy to announce the appointment of Dr. Stephan Beck to the Editorial Board of Cancer Epigenetics. Dr. Stephan Beck is Professor of Medical Genomics at University College London Cancer Institute (London, UK), and is one of the pioneers and

The Cancer Epigenetics Society is happy to announce the appointment of Dr. Tefferi, Mayo Clinic, to the Editorial Board of Clinical Cancer Epigenetics. Read more at https://ces.b2sg.org/ayalew-tefferi-editor/

ces.b2sg.org

Owen O'Connor, Editor of Clinical Cancer Epigenetics The Cancer Epigenetics Society is happy to announce the appointment of Dr. Owen A. O'Connor to the Editorial Board of Clinical Cancer Epigenetics. Dr. O’Connor is Professor of Medicine and Experimental Therapeutics at Columbia University and Director of the Center for Lymphoid Malignancies

In an effort to keep 'minority' languages alive, our first video in Gaelic, courtesy of Lisa McLoughlin & Dorottya Sáray! You may view it here (please subscribe if you like it): https://www.youtube.com/watch?v=u_MKnLj4WuY

Top 50 Countries Affected by Cancer (Gaeilge) 50 tír is mó atá faoi thionchar na hailse Is galar domhanda é an ailse; seans go mbeidh aon duine, ó aon tír nó aon chúla, ag aon aois, faoi thionchar na hai...

Stephen Baylin elected to the National Academy of Sciences, USA We are proud to announce that Prof. Stephen B. Baylin, Officer at the Cancer Epigenetics Society and Editor of Cancer Epigenetics, was elected to the National Academy of Sciences, USA. This distinction is in recognition of his work in basic and applied research

Our first video in Korean, courtesy of Yoo Jung Jin (진유정) & Dorottya Sáray! You may view it here (please subscribe if you like it): https://www.youtube.com/watch?v=lM53P37Ctw0

Top 50 Countries Affected by Cancer (한국어:조선말) 암에 의해 영향을 받는 상위 50 개 국가 암은 세계적인 질병입니다: 모든 국가 또는 인종 및 연령에 관계없이 누구든지 언젠가 암으로 진단받을 수 있습니다. 사실, 우리 모두는 고통받거나 암에 걸린 사람을 알고 있습니다. 국제 암 통제 연합(UICC)의 회원인 암 후성 유전학 학회...

Appointment of Cigall Kadoch, Editor of Cancer Epigenetics The Cancer Epigenetics Society is very happy to announce the appointment of Dr. Cigall Kadoch to the Editorial Board of the Cancer Epigenetics journals series. Dr. Kadoch is an expert of ATP-dependent mammalian SWI/SNF chromatin remodeling machineries, with a particular interest in

Appointment of Lucy Godley, Editor of Cancer Epigenetics The Cancer Epigenetics Society is very excited to announce the appointment of Dr. Lucy Godley to the Editorial Board of the Cancer Epigenetics journals series. Dr. Godley is an expert of myeloid malignancies with a particular interest in DNA methylation and hydroxymethylation role in

The Cancer Epigenetics Society is a COST-Epichembio Member The Cancer Epigenetics Society is as of July 1, 2017 a Full Member of Epichembio, an EU-funded initiative of the European Cooperation in Science and Technology (COST). Epichembio (Epigenetic Chemical Biology) regroups scientists and research institutions from 34 countries, making it one of the

The Cancer Epigenetics Society on YouTube The Cancer Epigenetics Society is now on YouTube with short videos relevant to cancer and/or epigenetics. The Society's first video follows the timeline of DNA-based epigenetics with several findings relevant to cancer biology or treatment. The second video highlights

The Cancer Epigenetics Society is a UICC Member The Cancer Epigenetics Society is as of June 15, 2017, a Full Member of the Union for International Cancer Control (UICC)! UICC is an NGO located in Geneva, Switzerland, that brings together an exclusive worldwide coalition of the major players in cancer control. It

Raul Urrutia, Chief Science Officer of the Cancer Epigenetics Society The Cancer Epigenetics Society is very excited to announce the appointment of Dr. Raul A. Urrutia as the Society's Chief Science Officer. Dr. Urrutia joins the leadership of the Cancer Epigenetics Society from the Mayo Clinic at Rochester where he holds full Professorships in

welcomes Anna Wilder to its team! Anna serves as the Assistant to the President and supports the coordination of several projects across the board. Anna has brought tremendous energy to the team and an international experience (Austria, Germany, Norway, USA) that further cements our goal to support cancer research and patients globally. We are very happy to have Anna as a team member and look forward to working with her for the many years to come!

welcomes Dorottya Sáray to its team! Dorottya serves as a Project manager and Legal advisor to the Society and is collaborating with several team members to expand both our services and reach. In addition to her skills and competence, Dorottya brings a lot of positive energy to the group and we look forward to her help in helping cancer patients!

Appointment of Cheryl Arrowsmith, Editor of Cancer Epigenetics The Cancer Epigenetics Society is very excited to announce the appointment of Dr. Cheryl H. Arrowsmith to the Editorial Board of Cancer Epigenetics journals series. Dr. Arrowsmith holds the Canada Chair in Structural Genomics and is Chief Scientist of the Structural Genomics Consortium (SGC) Toronto

The Cancer Epigenetics Society is 1 year old! The Cancer Epigenetics Society was on top of the world as it celebrated its 1st anniversary at the Loft restaurant and bar on the top floor of the Sofitel hotel in Vienna, Austria. The Cancer Epigenetics Society has achieved extraordinary progress in the relatively

The third annual Epigenetics Discovery Congress The Cancer Epigenetics Society is happy to announce its partnership with the 3rd Annual Epigenetics Discovery Congress that takes place in London, from the 12th to the 13th of October 2017. The meeting will cover several aspects of epigenetics and cancer epigenetics, including transgenerational

Appointment of Peter-Jones, Editor-in-Chief at CE The Cancer Epigenetics Society is very excited to announce the appointment of Dr. Peter Jones, Chief Scientific Officer of Van Andel Research Institute (VARI, Grand Rapids, MI, USA), as co-Editor-in-Chief of the Cancer Epigenetics journal series. Dr. Jones is a world renown DNA

Appointment of Jerry Workman, Editor at CE The Cancer Epigenetics Society is happy to announce the official appointment of Dr. Jerry Workman to the position of Editor at Cancer Epigenetics (CE) journal series. Dr. Workman is an Investigator at the Stowers Institute for Medical Research (Kansas City, MO, USA). Prior to

Dr. Sabine Oberhauser (30 August 1963 - 23 February 2017), here with Austria's President Heinz Fischer It is with great sadness that we learned of the passing of Dr. Sabine Oberhauser, Health Minister of Austria since 9/2014. Dr. Oberhauser suffered from cancer since early 2015. Not least among her many accomplishments is her commitment to fight cancer by forbiding smoking

Appointment of Sharon Dent, Editor-in-Chief at CE The Cancer Epigenetics Society is happy to announce the official appointment of Dr. Sharon Y. R. Dent to the position of co-Editor-in-Chief of the Cancer Epigenetics (CE) journal series. Dr. Dent is Professor and holds the J. Ralph Meadows Chair of

Appointment of Tatiana Kutateladze, Editor at CE The Cancer Epigenetics Society is happy to announce the official appointment of Dr. Tatiana Kutateladze to the position of Editor at Cancer Epigenetics (CE) journal series. Dr. Kutateladze is a Professor of Pharmacology at the University of Colorado School of Medicine (Aurora, CO, USA).

Cancer Epigenetics Society announces partnership with Treat Mesothelioma! Read Post here at https://ces.b2sg.org/treat-mesothelioma/

Cancer Epigenetics Society announces partnership with Treat Mesothelioma The Cancer Epigenetics Society enters into a partnership with Treat Mesothelioma to better support mesothelioma patients worldwide. Treat Mesothelioma is dedicated to the assistance and guidance of asbestos and mesothelioma victims around the world. Treat Mesothelioma is also meant to inspire hope a...